Close Menu

North America

Revenues were down year-over-year because of an international capital deal in the fourth quarter of 2019 that did not repeat in the current year.

The firm's head of strategy said now that it is a public company and paying down debt, Ortho can consider acquisitions that had been out of its reach.

Laboratory staffing and supply shortages limited patient access to cancer screening tests, and the pandemic decreased the development and validation of new tests.

In a recent commentary, the officials recounted the various factors that led to a troubled rollout of SARS-CoV-2 serology testing this spring.

A pair of studies published this week present an analysis of a real, large-scale testing pooling effort as well as analyses of how to further improve such strategies.

The fecal calprotectin test, which runs on the company's ProciseDx immunoassay system, is designed to help in the diagnosis of Crohn's disease and ulcerative colitis.

The expanded partnership includes a commercial agreement for the ClonoSeq and ImmunoSeq assays, as well as a lab service agreement for the T-Detect COVID test.

The lab will use its phlebotomy network to help Grail with specimen collection for its Galleri multi-cancer early detection blood test, slated to launch this year.

Cue said that US-based K-12 schools, essential businesses, nursing homes, hospitals, and physicians' offices are already using its COVID-19 test. 

The kit helps in the qualitative and semi-quantitative determination of anti-double stranded DNA IgG antibodies with the use of fluorescence microscopy.